Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$7.84M$7.84Mderived−2.3% vs Q4 2024 Net Income-$3.82M-$3.82MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$3,966,787N/M Operating Cash Flowderived$1,280,813−40.6% Free Cash Flowderived$1,213,587−43.5% Margins · derivedOperating margin-50.6%−49.1 pt vs Q4 2024
Net margin-48.7%−25.5 pt vs Q4 2024
ended Nov 30, 2025 · filed Feb 27, 2026 · 89 d after period end